Rothschild Biotech is the exclusive commercial operator of the Chengdu-Dayi-Anren (CDA) biotech corridor — a $50B+ life sciences opportunity. We bridge East and West through peptide therapeutics, APIs, biologics, and CDMO services. Led by Dr. Michael Rothschild MD.
Full tiered partner ecosystem — national flagships, local premier manufacturers, and Research and Development (R&D) institutions. Each partner is a critical node in Western China's integrated biotech industrial cluster.
The Rothschild family and key leaders driving the vision.
The Rothschild family's journey to China is one of resilience, love, and unwavering commitment to building bridges across cultures. Dr. Michael Rothschild MD, a descendant of the historic Rothschild banking dynasty, met his wife — whose family has roots in the Black Panther movement — in the United States. Their union, an interracial marriage, faced persecution in Israel, forcing the family to flee for their safety. They found refuge in China — a nation that welcomed them with open arms. Here, in Chengdu, they built a new life, a new legacy, and a new home. Their children, Sarah, Moises, China Jade, and Melina Ivy, represent the future of the Rothschild name — a multi-generational, multicultural family dedicated to building bridges between East and West through technology, culture, and industrial stewardship.
"We are not just building a company. We are building a legacy for our children, and their children, and all the generations to come." — Dr. Michael Rothschild MD
The Chengdu Biotech Belt — connecting Dayi-Anren to global biotech markets.
333 articles covering the Chengdu-Dayi-Anren (CDA) corridor, biotech technology, investment opportunities, and the Artemis Biotech Bridge™ initiative.
How can we help you? How can we work together? How can we build a legacy together?
RothschildM
333 Anren Ancient Town · Dayi County · Chengdu · Sichuan 611330 · PRC
Rothschild Biotech Limited
Hong Kong SAR · Registered
Est. 2007 · CCPFL Since Inception